Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature
Authors:
- 22 September 2006
- journal article
- review article
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 85 (2) , 127-132
Abstract
: Background: Retinal hamartoma is a common finding in tuberous sclerosis, but the symptomatic changes of this lesion have rarely been described. This evidence‐based review evaluated the incidence of symptomatic retinal hamartoma and compared possible treatment modalities. Methods: We carried out a review of the literature using MEDLINE. Older publications not listed in MEDLINE were obtained from the reference list of currently published papers.Results: Three observational case series with a follow‐up of up to 34 years included 93 patients and reported progression from a flat to a more elevated lesion without visual symptoms in nine patients (9.7%). Additional symptomatic changes were described in 11 case reports published over a period of three decades. The symptomatic alterations were caused by an enlarged tumour with leakage, macular oedema, accumulating lipoid exudates, serous retinal detachment (n = 8/11) and vitreous haemorrhage (n = 4/11). Most symptomatic cases involved a retinal hamartoma type 1 (n = 6/8). Spontaneous resolution of symptomatic exudative hamartomas occurred in three patients within 4 weeks, although a delayed resorption of subretinal fluid caused permanent visual impairment in one patient. Investigational reports described a slow resorption of subretinal fluid after argon laser photocoagulation (n = 2), although recurrent laser applications induced choroidal neovascularization and destruction of the neurosensory retina (n = 1). A vitrectomy was used to remove a vitreous haemorrhage in another reported patient. In one case, complete resorption of subretinal fluid and an increase in visual acuity was observed within 2 weeks after a single treatment with photodynamic therapy (PDT). No complications were noted during a follow‐up of 4 years.Conclusions: Symptomatic changes are very rare in retinal hamartomas secondary to tuberous sclerosis. Spontaneous resolution of subretinal fluid may occur within 4 weeks. If a macular oedema with increasing lipoid exudates persists over a period of 6 weeks, treatment should be considered. Although previous reports demonstrated possible visual stabilization after argon laser photocoagulation, vision‐threatening complications can occur. Current treatment strategies may include PDT based on favourable anatomical and functional results.Keywords
This publication has 25 references indexed in Scilit:
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- Spontaneous regression of retinal astrocytic hamartoma in a patient with tuberous sclerosisAmerican Journal of Ophthalmology, 2002
- Ophthalmic manifestations of tuberous sclerosis: a population based studyBritish Journal of Ophthalmology, 2001
- Hamartome astrocytaire parafovéolaire exsudatif associé à une sclérose tubéreuse de Bourneville: évolution spontannéeKlinische Monatsblätter für Augenheilkunde, 1997
- PHOTOCOAGULATION FOR SEROUS DETACHMENT OF THE MACULA SECONDARY TO RETINAL ASTROCYTOMARetina, 1991
- ATYPICAL RETINITIS PROLIFERANS, RETINAL TELANGIECTASIS, AND VITREOUS HEMORRHAGE IN A PATIENT WITH TUBEROUS SCLEROSISRetina, 1986
- Klinisches Bild und Verlaufsbeobachtungen beim astrozytären Hamartom der Netzhaut und der PapilleKlinische Monatsblätter für Augenheilkunde, 1984
- SPONTANEOUS REGRESSION OF PARAFOVEAL EXUDATES AND SEROUS RETINAL DETACHMENT IN A PATIENT WITH TUBEROUS SCLEROSIS AND RETINAL ASTROCYTOMASRetina, 1984
- Vitreous haemorrhage in tuberous sclerosis. Report of two cases.British Journal of Ophthalmology, 1973
- Augengeschwülste bei der tuberösen Hirnsklerose (Bourneville)Graefe's Archive for Clinical and Experimental Ophthalmology, 1921